Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

We have observed 2 EP applications Amy Helen Wilson has served for within the last five+ years. (We consider all applications which have an EP A1 publication dated after January 17, 2013). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP13705504

SEQUENCE SYMMETRIC MODIFIED IGG4 BISPECIFIC ANTIBODIES

IPC classification:
C07K 16/00
Applicant:
UCB Pharma S.A.
Applicant:
UCB Biopharma SPRL
Agent:
Amy Helen Wilson, UCB Celltech
Status:
PATENT GRANTED
EP13707824

SEQUENCE SYMMETRIC MODIFIED IGG4 BISPECIFIC ANTIBODIES

IPC classification:
C07K 16/00
Applicant:
UCB Pharma S.A.
Applicant:
UCB Biopharma SPRL
Agent:
Amy Helen Wilson, UCB Celltech
Status:
EXAMINATION IN PROGRESS

Please Sign in to use this feature